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We describe a new method for simultaneously identifying novel homologous genes with identical structure in the
human, mouse, and rat genomes by combining pairwise predictions made with the SLAM gene-finding program.
Using this method, we found 3698 gene triples in the human, mouse, and rat genomes which are predicted with
exactly the same gene structure. We show, both computationally and experimentally, that the introns of these triples
are predicted accurately as compared with the introns of other ab initio gene prediction sets. Computationally, we
compared the introns of these gene triples, as well as those from other ab initio gene finders, with known intron
annotations. We show that a unique property of SLAM, namely that it predicts gene structures simultaneously in two
organisms, is key to producing sets of predictions that are highly accurate in intron structure when combined with
other programs. Experimentally, we performed reverse transcription-polymerase chain reaction (RT-PCR) in both the
human and rat to test the exon pairs flanking introns from a subset of the gene triples for which the human gene
had not been previously identified. By performing RT-PCR on orthologous introns in both the human and rat
genomes, we additionally explore the validity of using RT-PCR as a method for confirming gene predictions.
[Supplemental material is available online at http://hanuman.math.berkeley.edu/∼cdewey/SLAMHMR/index.html.]
The difficulty of accurate ab initio gene finding has been well
documented (e.g., Mathe et al. 2002), and yet ab initio methods
remain important for identifying novel genes that may be rarely
expressed, have different structures from typical genes, or do not
have any known homologs and thus may have been missed by
conventional methods. The completion of the mouse genome
allowed for the first time a comparative-based annotation of the
human and mouse, and several methods were developed to take
advantage of the conservation between genes in order to en-
hance predictions (Waterston et al. 2002). Several assessments,
both computational (Burset and Guigó 1996) and experimental
(Guigó et al. 2003) have shown that comparative-based gene
finders such as SLAM (Alexandersson et al. 2003), Twinscan (Korf
et al. 2001), and SGP (Parra et al. 2003) outperform single-
organism gene finders such as Genscan (Burge and Karlin 1997)
and Genie (Reese et al. 2000).
Although comparative gene finders use sequence data from
multiple genomes, most only predict in one genome at a time.
Among gene finders that have been used to annotate entire ge-
nomes, a unique characteristic of the SLAM gene finder is its
simultaneous prediction of genes having identical structure in
two genomes. With the addition of a third genome, combining
the results from two SLAM runs allows for the prediction of genes
having identical structure in all three genomes. Previous studies
(e.g., Rogic et al. 2002) have shown that combining gene predic-
tions from different gene finders improves the accuracy of pre-
dictions. In this paper we combine SLAM gene predictions both
to extend predictions to a third genome and to improve accu-
racy. We analyze the accuracy of our three-way predictions, as
well as those resulting from combining predictions from other
gene finders, in terms of the accuracy of predicted introns.
Finally, we show that our strategy for gene prediction using
the human, mouse, and rat genomes leads to 924 novel human
gene predictions (along with corresponding mouse and rat or-
thologs). One intron from each of a subset of these genes (48 in
human and the corresponding 48 in rat) was experimentally
tested by reverse transcription-polymerase chain reaction (RT-
PCR) sequencing. Combined with our computational analysis,
the experiments suggest that up to roughly 80% of our novel
gene predictions correspond to transcribed sequence. Further-
more, the design of our experiments (simultaneous RT-PCR in
both human and rat tissue) provides a method for concurrent
validation of the RT-PCR technique for identifying novel gene
orthologs.
METHODS
A homology map was constructed for the human (November
2002), mouse (February 2002), and rat genomes (November
2002; Bray and Pachter, 2004). The map was designed so that the
maximal segment size was 300 kb; small enough for the subse-
quent running of the SLAM gene finder. The number of pieces
was 10,613 with a median length of 105,710 bases, and coverage
was 2.6 Gb (human), 2.3 Gb (mouse), and 2.3 Gb (rat). Two
whole-genome SLAM runs were performed, one using the human
and mouse genomes (which we refer to as the hm run), and the
other the human and rat genomes (the hr run). For each of the
runs, a pairwise homology map was projected from the three-way
map, and SLAM was run on each of the blocks.
In order to compare SLAM with other gene finders, whole-
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genome gene sets were obtained from the UCSC Genome
Browser Web site (Kent et al. 2002).
All available human (November 2002) gene sets from ab initio
gene finders (Geneid, Genscan, SGP, and Twinscan), as well as from
evidence-based methods (ENSEMBL, Known genes, and RefSeq)
were obtained. The ab initio sets along with the SLAM hm and
SLAM hr sets were each compared pairwise to produce “consensus”
sets of gene predictions that contained genes predicted identically
in human in two different sets. The accuracies of the introns of the
abinitio gene prediction sets and the consensus sets were measured
by comparison with the introns of the human RefSeq gene set.
The consensus set for the SLAM hm and hr runs contained
3698 genes. It is important to note that by virtue of the SLAM
constraints this set consisted of genes in human, mouse, and rat,
all predicted to have exactly the same structure. In compari-
son with the set of all SLAM hm predictions, the consensus set is
enriched for single-exon genes but has a similar distribution of
coding sequence length. In the interest of finding novel genes,
this set was filtered for those predictions that did not overlap at
all with genes in the ENSEMBL, Known genes, and RefSeq sets
(Guigó et al. 2003). This final set, which we call the filtered or-
tholog set, consisted of 924 genes.
We set out to confirm, using RT-PCR, one pair of exons
flanking an intron from each of a subset of the filtered ortholog
set in order to get an experimental estimate of the accuracy of
these predictions. Using Primer3 (Rozen and Skaletsky 1996) and
a variety of Perl scripts, the filtered ortholog set was screened for
introns at least 1000 bp in length and having flanking exons with
with suitably long primers (25–30 bp) capable of producing a PCR
product with a length between 150 bp and 200 bp and a suitable
melting temperature (67°–73°C).
Source RNA was pooled from 20 human tissues including
adrenal gland, bone marrow, brain cerebellum, brain (whole),
fetal brain, fetal liver, heart, kidney, liver, lung, placenta, pros-
tate, salivary gland, skeletal muscle, spleen, testis, thymus, thy-
roid gland, trachea, and uterus (Clontech Human Total RNA mas-
ter panel II), and 18 rat tissues including 10–12-d embryo, adre-
nal gland, bladder, brain (whole), brain cerebellum, colon, heart,
kidney, liver, lung, ovary, spleen, testicle, thymus (Clontech),
mammary gland, pancreas, placenta, and prostate (Ambion). Re-
verse transcription (RT) reactions were primed by OligodT using
Superscript II reverse transcriptase (Invitrogen). The RT reactions
were followed by PCR using Clontech Advantage 2 PCR Enzyme
System. The PCR program was set at 95°C for 30 sec, followed by
35 cycles of 95°C for 10 sec, and 68°C for 30 sec. Finally, there
was an extension cycle of 72°C for 1 min. The pair of exons
flanking each intron to be tested were amplified with specific
primers. RT-PCR products were examined by agarose gel electro-
phoresis (Figure 2, below). Kodak Digital Software was used to
estimate the product sizes. PCR products were purified with a
QIAquick 96-well PCR purification kit (QIAGEN) and sequenced
using both forward and reverse primers for each predicted gene.
The amplified sequences were compared with the original
SLAM predictions to verify the identity of recovered products.
Sequence alignments were computed using standard penalties
(match +1, mismatch 1, gap 2, gapExtend 1) and the re-
sulting alignments were considered “valid” if they were at least
40 bp long, overlapped the boundaries of the predicted intron
with its flanking exons, and contained 75% sequence similarity
(determined by counting the number of matches and dividing by
the alignment length). An intron was considered to be verified if
the sequenced product had a valid alignment with the predicted
product. The gene predictions for which the introns were tested
were also subject to further analysis in the form of BLAST align-
ments against standard databases, and comparison with other
existing gene annotations and EST evidence.
RESULTS
The results of the SLAM gene finding runs, the comparison of the
intron predictions with known introns, and the confirmation of
the intron predictions by RT-PCR are summarized in Table 1. The
accuracy of the introns of all available ab initio whole-genome
gene prediction sets and of the consensus sets generated from
each pair is shown in Figure 1. A companion Web site at http://
hanuman.math.berkeley.edu/∼cdewey/SLAMHMR/index.html
shows the tested genes, with information about the RT-PCR ex-
periments and subsequent analysis. The genes are clickable to
show the predictions in context on the UCSC genome browser
(Kent et al. 2002), and the RT-PCR results (from two separate ex-
periments) are summarized and the alignments of the sequence
products are displayed. Finally, a short description of each gene
is included with highlights of peculiar features of interest.
We mention a few interesting examples: the gene
M4H1U1D4r70.005 contains five exons, and has an intron that
was validated only in rat. The gene appears inside the intron of a
known gene (NMNAT) but in the opposite strand. The gene
M16H3U2D1r112.003 (validated in both human and rat) is
known only in mouse, but the human/mouse gene predictions
align with 97% identity and the human rat also with 97% iden-
tity. In fact, the prediction is part of an 18-exon gene (>1000
amino acids) that was known only in mouse! This illustrates the
power of the comparative method to not only identify novel
genes, but to extend annotations from one organism to another.
DISCUSSION
Our analysis of the accuracy of the introns of currently available
whole-genome ab initio gene prediction sets and consensus sets
generated from them reveals several important facts. First, un-
surprisingly, comparative gene finders produce more accurate in-
tron predictions than noncomparative ab initio gene finders. Ev-
ery comparative gene prediction set analyzed (SGP, SLAM hm,
SLAM hr, and Twinscan) had higher intron accuracy than the
noncomparative gene prediction sets (Genscan and Geneid). In
terms of exact intron predictions, the noncomparative gene pre-
diction sets had a mean accuracy of 68% whereas the compara-
tive sets had a mean accuracy of 77%.
The consensus gene prediction sets greatly improve accu-
racy (up to 98% accuracy), but at a large loss of sensitivity (the
most accurate sets had just below 1000 introns overlapping a
RefSeq intron). Figure 1 shows that similar gene finders, such as
Table 1. Summary Statistics
# of SLAM human/mouse genes 29370
# of SLAM human/rat genes 25427
# of SLAM genes identical in human,
mouse, and rat
3698
# of SLAM human/mouse/rat introns 10577
# of SLAM human/mouse/rat introns
overlapping human RefSeq introns
8499
% of SLAM human/mouse/rat introns
with correct structure (out of introns
overlapping human RefSeq)
90%
# of novel (not overlapping with human
Ensembl, RefSeq, or Known genes)
SLAM human/mouse/rat genes
924
# of SLAM human/mouse/rat introns
tested
48 ortholog pairs
(48 human, 48 rat)
% of SLAM human/mouse/rat introns
verified
73% (28 pairs verified in
both human and rat,
6 verified only in rat,
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Twinscan and Genscan or SGP and Geneid, give rise to larger
consensus sets with lower accuracy. It follows from this observa-
tion that the most dissimilar gene finders can be combined to
give the most accurate consensus sets. A case of combining the
results from extremely similar gene finders is the SLAM hm/SLAM
hr consensus set, which utilizes the same exact gene finder but
different comparative data sets. Of all the consensus sets, this set
is the largest and has the lowest accuracy. It strikes a good com-
promise between accuracy and sensitivity, with about 8500 in-
tron predictions overlapping RefSeq introns and an accuracy of
90%, a 10% improvement over the accuracy obtained by the best
comparative gene finders by themselves. The largest consensus
set with accuracy above 91% (Twinscan/SGP) has only 4806 pre-
dictions. It is important to note that the SLAM hm/SLAM hr set is
also unique in that it represents simultaneous predictions of or-
thologs in the human, mouse, and rat genomes.
The fact that SLAM is required for all consensus sets with
accuracy greater than 96% indicates that SLAM is quite different
than other gene finders. The most accurate consensus sets had
accuracies up to 98% and were those resulting from combining
SLAM with the two noncomparative gene finders, Genscan and
Geneid. Some aspect of SLAM’s comparative nature must account
for its uniqueness, as SLAM and Genscan are based on very simi-
lar gene models. As the consensus sets involving the other com-
parative gene finders had lower accuracy than those involving
SLAM, it is likely that it is SLAM’s ability to predict simulta-
neously in two genomes (Pachter et al. 2002) that sets it apart
from the other gene finders and allows for more accurate con-
sensus sets. Unfortunately, this analysis shows that there is much
room for improvement in gene-finding models; we are still far
from having a gene finder that it is both sensitive and accurate in
terms of intron structure, as the sets with
accuracy of at least 90% all had less than
9000 intron predictions (the RefSeq an-
notation set contains around 150,000
introns). This reflects our continued lack




In other computational analyses
where we have analyzed exon and
whole-gene structure accuracy, the re-
sults are essentially the same as for the
intron analysis (see Supplemental Data).
Consensus sets including SLAM have the
highest accuracies: up to 95% at the
exon level, and 83% at the whole-gene
level. Interestingly, consensus-set intron
accuracy was greater than consensus-set
exon accuracy, and nonconsensus-set
intron accuracy was lower than noncon-
sensus-set exon accuracy. This suggests
that introns are generally harder to pre-
dict accurately than exons, but that by
using gene-finder consensus, the task be-
comes much easier. This seems impor-
tant in light of the fact that RT-PCR ex-
periments validate introns and not exons.
Our RT-PCR intron validation rates
(60% in human, 71% in rat, 66% overall,
and 73% for intron pairs when requiring
validation in only one organism) are en-
couraging compared to the rates ob-
tained in a previous study by Guigó et al.
(2003). In that study, RT-PCR validation
rates obtained for predicted mouse introns were 62% for all in-
trons and 76% for introns predicted by two different programs
(SGP and Twinscan). We are encouraged by this comparison, as
we were looking for novel transcripts in the human genome (and
not in mouse). Because the human genome is much better char-
acterized, it seems that it should be harder to detect novel genes,
and indeed many of our products were only expressed in a small
fraction of tissues. The fact that only seven out of 48 tested genes
were validated in only one organism reinforces the idea that
RT-PCR is a legitimate method for validating genes. In three of
these seven cases, an amplified product similar to the predicted
product was sequenced in the other organism, but did not have
a good enough alignment with the predicted product (perhaps
due to sequence quality issues) to be considered validated. These
results confirm the intuition that SLAM gene predictions are cor-
rect in both orthologs or in neither. It also suggests that genes
rarely expressed in one organism may be rarely expressed in an-
other. Despite the correlated results, our tests confirm that mul-
tiple RT-PCR in different organisms improves gene validation
rates.
Although we did not explicitly study alternative splicing here,
we have implemented a sampling strategy for SLAM in which it
is possible to sample alternative orthologous transcripts instead
of obtaining just one prediction (Cawley and Pachter 2003). Pre-
liminary testing suggests that the human–mouse, human–rat
prediction SLAM run combination described in this paper should
yield alternative transcripts conserved between the mammals. At
this point, the extent of such conservation is still unclear (Modrek
and Lee 2003; Nurtdinov et al. 2003; Thanaraj et al. 2003).
By using our intron accuracy rates obtained both computa-
tionally and experimentally, we can make an estimate of the
Figure 1 Enrichment for intron accuracy by gene prediction consensus. Intron accuracy of gene
predictions by SLAM, other ab initio programs, and from consensus sets was measured by agreement
with human RefSeq annotations. Comparative gene predictions utilizing two genomes were more
accurate than those from noncomparative gene finders (Genscan and Geneid). Genscan, a noncom-
parative gene finder, had the greatest sensitivity, with close to 130,000 intron predictions overlapping
RefSeq introns. Combining gene predictions to form consensus sets greatly increases accuracy while
significantly reducing sensitivity. The vertical dotted line indicates the limit of the accuracy of consen-
sus sets not involving SLAM.
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number of novel gene predictions obtained by our method. If we
assume that the RefSeq gene annotation set is somewhat repre-
sentative of the entire human gene set, then we estimate from
our computational analysis that given that a SLAM hm/SLAM hr
predicted intron overlaps with a real intron, it will be 100% ac-
curate 90% of the time. Because of our RT-PCR procedures, we
could only validate predicted introns that were 100% accurate.
Therefore, given a 73% validation rate for our predicted introns
(where we consider an intron validated if the predicted product is
sequenced in either organism), we estimate that 0.73/0.90 = 81%
of the introns in the SLAM hm/SLAM hr set overlap with a real
gene. With 322 genes from the filtered ortholog set (potentially
novel genes) possessing one or more introns, a rough estimate of
the number of novel multiexon genes that can be discovered and
validated (by RT-PCR validation of an intron) through this
method is 322 81% = 260.
It is important to note that RT-PCR validations of predicted
genes, as undertaken here as well as by Guigó et al. (2003), are
conditioned on the ability to select suitable primer pairs. Although
our success rate suggests that we can identify many new genes in
the human genome, a direct extrapolation is likely inacurrate
because of the difficulty in selecting primers in some of the ex-
amples. RT-PCR validations of predicted genes are also affected
by the gene expression locations and time. Some genes may not
have been validated due to our limited RNA source. Furthermore,
our results on the validation of novel genes should be interpreted
more strictly as validation of transcribed regions, because the
experiments do not directly measure protein concentration levels.
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Figure 2 Gels used as part of RT-PCR validation of predicted introns. RT-PCR was used to validate one
intron from 48 predicted novel human genes and their simultaneously predicted rat orthologs. The
gels contain the RT-PCR sequenced products from human (A) and rat (B). Each column in the gel
contains the sequenced product for one intron tested, with the same columns in the human and rat
gels containing products from orthologous predictions. The leftmost and rightmost columns contain
the ladders used to determine the lengths of the sequenced products. The second column contains a
positive control (RT-PCR of an exon-pair from actin), and the third column contains a negative control
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